Skip to main content

Advertisement

Table 1 Demographic data at baseline

From: Validation of the relevant outcome scale for Alzheimer's disease: a novel multidomain assessment for daily medical practice

  Early stage Middle stage Late stage Overall
Age (years) 74.1 (7.91) 76.3 (7.12) 78.3 (6.07) 75.7 (7.4)
Gender, female 84 (52.2%) 100 (57.1%) 41 (67.2%) 225 (56.7%)
White 161 (100.0%) 175 (100.0%) 61 (100.0%) 397 (100%)
Weight (kg) 74.0 (13.7) 72.0 (15.1) 67.6 (11.5) 72.1 (14.1)
Height (cm) 167.0 (8.9) 165.1 (9.1) 164.0 (8.1) 165.7 (8.89)
MMSE score 23.3 (4.2) 18.6 (5.2) 12.5 (5.5) 19.6 (6.1)
ADAS-cog score 16.3 (6.4) 23.4 (8.4) - 20.0 (8.3)
SIB scorea - 79.1 (11.3) 62.6 (20.3) 74.7 (16.0)
DAD score 33.3 (6.8) 24.7 (9.4) 13.8 (8.3) 26.4 (10.6)
NPI score 9.7 (9.6) 14.1 (11.7) 22.2 (14.4) 13.9 (12.3)
  1. Data presented as mean (standard deviation) or number (%) of patients (full analysis set). ADAS-cog, Alzheimer's Disease Assessment Scale - cognitive subscale; DAD, Disability Assessment for Dementia; MMSE, Mini-Mental State Estimation; NPI, Neuropsychiatric Inventory; SIB, Severe Impairment Battery.aQuestions 1, 39, and 40 were omitted in this study.